Published in Cochrane Database Syst Rev on October 17, 2012
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old (VESTRI) | NCT01462344
Outpatient management of asthma in children. Clin Med Insights Pediatr (2013) 0.80
Evaluation of AMSTAR to assess the methodological quality of systematic reviews in overviews of reviews of healthcare interventions. BMC Med Res Methodol (2017) 0.75
Safety of long-acting beta agonists and inhaled corticosteroids in children and adolescents with asthma. Ther Adv Drug Saf (2013) 0.75
The Danish National Database for Asthma: establishing clinical quality indicators. Eur Clin Respir J (2016) 0.75
Assessing the methodological quality of systematic reviews. NPJ Prim Care Respir Med (2015) 0.75
A systematic review of adverse drug events associated with administration of common asthma medications in children. PLoS One (2017) 0.75
Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA (2004) 23.87
Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet (2004) 18.69
Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol (2007) 13.46
Interaction revisited: the difference between two estimates. BMJ (2003) 11.97
Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med (2004) 11.47
Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ (2004) 10.75
The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol (1997) 9.01
The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest (2006) 8.43
Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA (2001) 8.15
Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. Ann Intern Med (2006) 7.83
Bronchial hyperreactivity. Am Rev Respir Dis (1980) 4.77
Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat Med (2007) 4.56
Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet (2008) 3.71
Regular treatment with salmeterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2008) 2.38
Assessing the safety of adding LABAs to inhaled corticosteroids for treating asthma. N Engl J Med (2011) 1.91
Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2010) 1.58
Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. Cochrane Database Syst Rev (2010) 1.52
Life-threatening asthma during treatment with salmeterol. N Engl J Med (2006) 1.40
Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children. Cochrane Database Syst Rev (2009) 1.33
Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action. Eur Respir J (1996) 1.33
Age and risks of FDA-approved long-acting β₂-adrenergic receptor agonists. Pediatrics (2011) 1.13
Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma. Cochrane Database Syst Rev (2011) 1.00
Regular treatment with formoterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2012) 0.98
Canadian Thoracic Society Asthma Committee commentary on long-acting beta-2 agonist use for asthma in Canada. Can Respir J (2010) 0.96
Comparative protective effect of the inhaled beta 2-agonist salbutamol (albuterol) on bronchoconstriction provoked by histamine, methacholine, and adenosine 5'-monophosphate in asthma. J Allergy Clin Immunol (1990) 0.95
Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2009) 0.93
Current issues with beta2-adrenoceptor agonists: historical background. Clin Rev Allergy Immunol (2006) 0.92
Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2009) 0.91
Safety of tiotropium. BMJ (2011) 0.85
Airway hyperresponsiveness as a determinant of the early asthmatic response to inhaled allergen. J Asthma (2006) 0.83
Acupuncture for irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol (2012) 1.76
The Cochrane Library and safety of systemic corticosteroids for acute respiratory conditions in children: an overview of reviews. Evid Based Child Health (2014) 1.46
Ethanol in formularies of US teaching hospitals. JAMA (2003) 1.44
Positioning of the Alzheimer Abeta(1-40) peptide in SDS micelles using NMR and paramagnetic probes. J Biomol NMR (2007) 1.30
Acupuncture for treatment of irritable bowel syndrome. Cochrane Database Syst Rev (2012) 1.05
Methodological developments in searching for studies for systematic reviews: past, present and future? Syst Rev (2013) 0.95
An evaluation of epidemiological and reporting characteristics of complementary and alternative medicine (CAM) systematic reviews (SRs). PLoS One (2013) 0.95
Potent side-chain to side-chain cyclized dermorphin analogues containing a carbonyl bridge. J Pept Sci (2003) 0.95
An evaluation of the completeness of safety reporting in reports of complementary and alternative medicine trials. BMC Complement Altern Med (2011) 0.95
Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children. Cochrane Database Syst Rev (2013) 0.93
Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2013) 0.92
Randomised clinical trials on acupuncture in the Korean literature: bibliometric analysis and methodological quality. Acupunct Med (2013) 0.87
Experimental investigation of initial steps of helix propagation in model peptides. Biochemistry (2003) 0.87
Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews. Cochrane Database Syst Rev (2014) 0.87
Overview of reviews in child health: evidence synthesis and the knowledge base for a specific population. Evid Based Child Health (2013) 0.83
Hospital Use of Ethanol Survey (HUES): preliminary results. J Addict Dis (2002) 0.82
N-(ureidoethyl)amides of cyclic enkephalin analogs. J Pept Sci (2009) 0.80
Treatment of acute gastroenteritis in children: an overview of systematic reviews of interventions commonly used in developed countries. Evid Based Child Health (2013) 0.78
Cyclic enkephalin and dermorphin analogues containing a carbonyl bridge. J Pept Sci (2005) 0.78
Massage for Low-back Pain. Explore (NY) (2016) 0.78
Conformational studies of vasopressin and mesotocin using NMR spectroscopy and molecular modelling methods. Part II: Studies in the SDS micelle. J Pept Sci (2008) 0.78
The carboxyl-terminal segment of apolipoprotein A-V undergoes a lipid-induced conformational change. Biochemistry (2010) 0.77
Ensemble fits of restrained peptides' conformational equilibria to NMR data. Dependence on force fields: AMBER/8 ff03 versus ECEPP/3. J Mol Graph Model (2011) 0.76
Cyclic enkephalin-deltorphin hybrids containing a carbonyl bridge: structure and opioid activity. Acta Biochim Pol (2011) 0.75
Conformational solution studies of the SDS micelle-bound 11-28 fragment of two Alzheimer's beta-amyloid variants (E22K and A21G) using CD, NMR, and MD techniques. Biopolymers (2007) 0.75
WITHDRAWN: Vitamin C supplementation for asthma. Cochrane Database Syst Rev (2013) 0.75
Ureido group containing cyclic dermorphin(1-7) analogues: synthesis, biology and conformation. J Pept Sci (2007) 0.75
Solution structure of conformationally restricted vasopressin analogues. Acta Biochim Pol (2004) 0.75